Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +61.3% | +15.0% | 2 / 3 | +19.0% | +3.68 pp | +2.82 pp | +14.3% | 0.00 | 9.12 | 583 | +19,0% | 62,6 | +61,3% | 9.12 | 10.84 | −15,9% |
| Pts | 12 | 0 | 8 | 8 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.800 (close price on 2026-10-15)EPS (TTM): 1.952
Financial charts
1.Revenue & growth
VND bn583Q2/26
1.Revenue & growth
VND bn583Q2/26
2.Profit & growth
VND bn62,6Q2/26
3.Profit mix (Penman)
VND bn213Q2/26
4.Margins & cost structure
%33.4%Q2/26
5.Returns & cash cycle
% · days48.2%Q2/26
6.Earnings quality & cash
VND bn212Q2/26
7.Asset structure
VND bn1.555Q2/26
8.Funding & debt health
VND bn · times1.555Q2/26
9.Revenue backlog
VND bn14,2Q2/26
10.Valuation
times · %9,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %718Q2/26
Adjusted EPS growth, latest quarter
61.3%
Average adjusted EPS growth, 3 quarters
15.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26